Ross D'lima

Partner

伦敦 + 44.20.7039.5718

联系：

Share

Ross D'lima advises on a wide range of corporate transactions covering early-stage venture capital, growth capital, CVC (corporate venture capital), M&A and venture-backed exits, and joint ventures. Ross has advised at all stages of the company life cycle, from pre-seed up to exit, advising both investors and companies. Ross advises a wide range of clients within the tech and life sciences sectors and is part of the Jones Day fintech team comprised of more than 175 lawyers globally.

Transactions in which Ross has been the lead include: advising Raine via its growth equity fund on the Series C financing of Midnite; advising Eli Lilly in the £90m financing of Myricx; advising Elaia Partners on its investment in the Series B funding round of Doccla; representing Quadrille in its participation in the $500 million Series E financing of Jobandtalent; advising Shopify on its investment in the $100 million Series C financing of Codat; representing early-stage venture capital fund Passion Capital on the sale of automotive data insights platform Cazana to Cazoo; advising a global investment manager on the £580m funding round of SumUp; advising Deezer on its Series A and Series B financing of Driift; and advising Meriuex Equity Partners, Illumina Ventures, and Heran Partners on their $15m Series A financing of Broken String Biosciences.

经验

  • Raine leads $35 million Series C financing of MidniteJones Day advised Raine via its Raine Partners IV growth equity fund in its role as lead investor in the $35 million Series C financing of Midnite, a London-based eSports betting operator.
  • Elaia Partners participates in $2.7 million financing of StreambasedJones Day advised Elaia Partners in connection with the $2.7 million financing of Streambased to accelerate streaming data analytics adoption.
  • BizAway raises €35 millionJones Day advised BizAway in connection with all aspects of the €35 million Series B investment provided by Mayfair Equity Partners to accelerate BizAway's growth in existing markets and expand into new ones, including artificial intelligence strategies, and development of additional products and services to address the challenges and frustrations faced by business travelers.
  • Elaia Partners participates in £35 million Series B financing of DocclaJones Day advised Elaia Partners in connection with its participation in the £35 million Series B financing of Doccla, the leading provider of virtual ward and remote patient monitoring services, particularly targeting France and the DACH region for expansion while also positioning the company for potential growth in other international markets beyond Europe.
  • Bristol Myers Squibb invests in Series B financing of NeoPhore LtdJones Day advised Bristol Myers Squibb (NYSE: BMY) in the Series B financing of NeoPhore Ltd.
  • Eli Lilly participates in £90 million ($114 million) Series A financing of MyricxJones Day advised Eli Lilly and Company in connection with the £90 million ($114 million) Series A financing of Myricx, a UK biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs).
  • Mérieux Equity Partners, Illumina Ventures and Heran Partners invest in Broken String BiosciencesJones Day advised Mérieux Equity Partners, Illumina Ventures and Heran Partners in the Series A financing of Broken String Biosciences, a genomics company based in the UK.
  • Affinity Partners leads €207 million Series F financing of EGYMJones Day represented Affinity Partners in its acquisition of an interest in EGYM, a global fitness technology and corporate health innovation leader, in a Series F financing of €107 million, with an additional €100 million available for future investments.
  • Impact Partners invests in We Are DigitalJones Day advised Impact Partners, Europe's largest Impact fund, in the $6.6 million Series A financing of We Are Digital, a tech-for-good company building the world’s first one-stop-shop platform to run welfare services more efficiently.
  • Adelie Capital invests in LandytechJones Day advised Adelie Capital in the $12 million Series B financing of Landytech.
  • Koch sells Sense Biodetection to Sherlock BiosciencesJones Day advised Koch Disruptive Technologies, LLC in the sale of Sense Biodetection, a global molecular diagnostics innovator, to Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point of need.
  • Deezer invests to create livestreaming powerhouse as Driift acquires DreamstageJones Day advised Deezer S.A. in its £4 million investment in the merger of Driift and Dreamstage, creating a livestreaming powerhouse.
  • FleetCor invests in Zap-Map Jones Day advised FleetCor Technologies, Inc. in the £5.3 million Series A financing of Next Green Car (d/b/a Zap-Map), the UK’s leading EV charging point mapping service.
  • Alternative investment management firm participates in €590 million growth equity funding round of global fintech payments platformJones Day advised an alternative investment management firm in connection with participation in a €590 million growth equity funding round of a global fintech payments platform.
  • Riverside sells Brookson to People2.0Jones Day advised The Riverside Company in the sale of Brookson Group Limited to People2.0, a TPG portfolio company.
  • Shopify participates in $100 million Series C growth equity financing of CodatJones Day represented Shopify, the e-commerce platform, in connection with its participation in the $100 million Series C growth equity financing of Codat, the universal API for small business data.
  • Kalray acquires Arcapix Holdings Ltd.Jones Day advised Kalray in the acquisition of Arcapix Holdings Ltd, a UK headquartered company that offers high-performance storage and data management solutions for intensive and critical data.
  • Sofinnova leads €15 million Series A financing round of GFBiochemicalsJones Day advised Sofinnova Partners, as lead investor, with participation from Sparta Capital, in the €15 million Series A financing round of GFBiochemicals to accelerate GFBiochemicals' mission to end chemical pollution by helping fast moving consumer goods (FMCG) and industrial companies transition away from using toxic, environmentally harmful petrochemicals in everyday products.
  • Krafton leads $11 million Series B round of financing of TamatemJones Day advised Krafton, a South Korean game developer, in leading the $11 million Series B financing round of Tamatem, a mobile game publisher based in Jordan.
  • 360Learning acquires LooopJones Day advised 360Learning, the global collaborative learning SaaS leader, in its acquisition of Looop Online Limited, the UK's leading and top-rated learning management system.
  • Quadrille Capital participates in $500 million Series E financing round of JobandtalentJones Day advised Quadrille Capital SAS in connection with participation in the $500 million Series E round of financing of jobandtalent, the world's leading digital temp staffing agency that uses AI to match workers to casual labor jobs in sectors like warehousing, commerce, and logistics.
  • Deezer buys minority stake in livestream company DriiftJones Day advised Deezer in its minority investment in Driift Holdings Limited, a producer and promoter of live streamed events.
  • True Capital acquires majority stake in SneakJones Day advised True Capital Ltd in the acquisition of a majority stake in D2C zero sugar, energy drink business, Sneak.
  • Passion Capital sells UK Vehicle Ltd to Cazoo Holdings LimitedJones Day advised Passion Capital in the sale of the entire issued share capital of UK Vehicle Ltd, a data services business, to Cazoo Holdings Limited; and the immediate repurchase of the entire issued share capital of Car and Classic Holdings Ltd, a subsidiary company of UK Vehicle Ltd, by certain parties including Passion Capital.
    •

    发送前请注意

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice